HIGHLIGHTS
- who: Hsiang-Yuan Lin and colleagues from the Editor:, University: Canada have published the Article: Nabilone treatment for severe behavioral problems in adults with intellectual and developmental disabilities: Protocol for a phase I open-label clinical trial, in the Journal: PLOS ONE of 12/04/2023
- what: The authors propose this first-ever Phase I pre-pilot open-label clinical trial to obtain preliminary data on the adherence tolerability and safety profiles of nabilone in adults with IDD and explore changes in SBPs pre- to post-treatment. As SBPs often poses major Nabilone for aggression . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.